Impact of transcription factors AP-1 and NF-κB on the outcome of experimental Staphylococcus aureus arthritis and sepsis
- 30 June 2001
- journal article
- Published by Elsevier in Microbes and Infection
- Vol. 3 (7) , 527-534
- https://doi.org/10.1016/s1286-4579(01)01408-3
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Distinct roles for the NF-κB1 (p50) and c-Rel transcription factors in inflammatory arthritisJournal of Clinical Investigation, 2000
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998
- Studies on the contribution of c-fos/AP-1 to arthritic joint destruction.Journal of Clinical Investigation, 1997
- The AP-1 site and MMP gene regulation: What is all the fuss about?Matrix Biology, 1997
- In situ hybridization analysis of synovial and systemic cytokine messenger RNA expression in superantigen‐mediated Staphylococcus aureus arthritisArthritis & Rheumatism, 1996
- Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitor.The Journal of Experimental Medicine, 1995
- Role of T Lymphocytes in Experimental Staphylococcus aureus ArthritisScandinavian Journal of Immunology, 1994
- Functional discrimination between interleukin 6 and interleukin 1European Journal of Immunology, 1988
- Production of hybridoma growth factor by human monocytesEuropean Journal of Immunology, 1987
- Staphylococcus aureusNew England Journal of Medicine, 1984